| Announce Date | 02/02/2026 |
| EPS Normalized Actual | $1.17 (Beat by $0.22) |
| EPS GAAP Actual | $1.17 (Beat by $0.22) |
| Revenue Actual | $0.605615B |
| Revenue Surprise | Beat by $605.615M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.7 |
| EPS GAAP Estimate | $1.7 |
| Revenue Estimate | $0.262488014B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 0 | INF | 0 | 0 | 1 |
| Sep 2029 | 3.86 | 13.58 | 3.54863 | 4.06551 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.22 | 0.73 | 0.605615B | 19.36% | -28.81M |
| FQ3 2025 (Sep 2025) | 0.15 | -0.03 | 0.336078B | -17.76% | -302.79M |
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 0.298946B | 7.8% | 298.95M |
| FQ1 2025 (Mar 2025) | 2.04 | 2.04 | 0.913027B | 27.54% | 913.03M |
| FQ4 2024 (Dec 2024) | 1.32 | 1.32 | 0.488361B | 4.33% | 488.36M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.39578B | 16.29% | 395.78M |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 0.275636B | 4.19% | 275.64M |
| FQ1 2024 (Mar 2024) | 1.23 | 1.23 | 0.661564B | 2.65% | 661.56M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.7
Consensus Revenue Estimates
0.262488014B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0.18 | -- | 0.17542 | 0.18458 | 1 |
| FQ1 2028 (Mar 2028) | 1.77 | -- | 1.72495 | 1.81503 | 1 |
| FQ4 2027 (Dec 2027) | 1.18 | -- | 1.14997 | 1.21002 | 1 |
| FQ2 2027 (Jun 2027) | -0.14 | -- | -0.14 | -0.14 | 1 |
| FQ1 2027 (Mar 2027) | 1.76 | -- | 1.71455 | 1.80544 | 1 |
| FQ4 2026 (Dec 2026) | 1.15 | -6.09 | 1.1203 | 1.17969 | 1 |
| FQ2 2026 (Jun 2026) | 0.07 | 314.29 | 0.07 | 0.07 | 1 |
| FQ1 2026 (Mar 2026) | 1.7 | -20 | 1.7 | 1.7 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0.32B | -- | 0.31B | 0.32B | 1 |
| FQ1 2028 (Mar 2028) | 0.32B | -- | 0.31B | 0.32B | 1 |
| FQ4 2027 (Dec 2027) | 0.32B | -- | 0.31B | 0.33B | 1 |
| FQ2 2027 (Jun 2027) | 0.33B | -- | 0.33B | 0.33B | 1 |
| FQ1 2027 (Mar 2027) | 0.82B | -- | 0.8B | 0.83B | 1 |
| FQ4 2026 (Dec 2026) | 0.57B | -5.53 | 0.56B | 0.59B | 1 |
| FQ2 2026 (Jun 2026) | 0.47B | 36.17 | 0.47B | 0.47B | 1 |
| FQ1 2026 (Mar 2026) | 0.26B | -247.84 | 0.26B | 0.26B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.49 | 1.22 | 0.73 | 59.84% |
| FQ3 2025 (Sep 2025) | 0.18 | 0.15 | -0.03 | -20% |
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 100% | |
| FQ1 2025 (Mar 2025) | 2.04 | 2.04 | 100% | |
| FQ4 2024 (Dec 2024) | 1.32 | 1.32 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
| FQ1 2024 (Mar 2024) | 1.23 | 1.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.63B | $0.61B | $-28.81M | -4.76% |
| FQ3 2025 (Sep 2025) | $0.64B | $0.34B | $-302.79M | -90.09% |
| FQ2 2025 (Jun 2025) | $0B | $0.3B | $298.95M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.91B | $913.03M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.49B | $488.36M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.4B | $395.78M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.28B | $275.64M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.66B | $661.56M | 100% |